Utilize este identificador para referenciar este registo: http://hdl.handle.net/10400.4/1710
Título: Ophthalmic adverse drug reactions to systemic drugs: a systematic review
Autor: Miguel, A
Henriques, F
Azevedo, LF
Pereira, AC
Palavras-chave: Reacções Adversas e Efeitos Secundários a Medicamentos
Doenças dos Olhos
Data: 2014
Editora: Wiley
Citação: Pharmacoepidemiol Drug Saf. 2014;23(3):221-33.
Resumo: PURPOSE: To perform a comprehensive and systematic review regarding ophthalmic adverse drug reactions (ADRs) to systemic drugs to: (i) systematically summarize existing evidence, (ii) identify areas, ophthalmic ADRs or drugs that lacked systematization or assessment (namely drugs with original studies characterizing specific ophthalmic ADRs but without causality assessment nor without meta-analysis). METHODS: Systematic review of several electronic databases (last search 1/7/2012): Medline, SCOPUS, ISI web of knowledge, ISI Conference Proceedings, International Pharmaceutical Abstracts and Google scholar. Search query included: eye, ocular, ophthalmic, ophthalmology, adverse and reaction. Inclusion criteria were: (i) Primary purpose was to assess an ophthalmic ADR to a systemic medication; (ii) Patient evaluation performed by an ophthalmologist; (iii) Studies that specified diagnostic criteria for an ocular ADR. Different types of studies were included and analyzed separately. Two independent reviewers assessed eligibility criteria, extracted data and evaluated risk of bias. RESULTS: From 562 studies found, 32 were included (1 systematic review to sildenafil, 11 narrative reviews, 1 trial, 1 prospective study, 6 transversal studies, 6 spontaneous reports and 6 case series). Drugs frequently involved included amiodarone, sildenafil, hydroxychloroquine and biphosphonates. Frequent ophthalmic ADRs included: keratopathy, dry eye and retinopathy. CONCLUSIONS: To increase evidence about ophthalmic ADRs, there is a need for performing specific systematic reviews, applying strictly the World Health Organization's (WHO) definition of ADR and WHO causality assessment of ADRs. Some ophthalmic ADRs may be frequent, but require ophthalmological examination; therefore, ophthalmologists' education and protocols of collaboration between other specialties whenever they prescribe high-risk drugs are suggestions for the future.
Peer review: yes
URI: http://hdl.handle.net/10400.4/1710
Aparece nas colecções:OFT - Artigos

Ficheiros deste registo:
Ficheiro Descrição TamanhoFormato 
Ophthalmic adverse drug reactions to systemic drugs.pdf377,88 kBAdobe PDFVer/Abrir


Todos os registos no repositório estão protegidos por leis de copyright, com todos os direitos reservados.